This protein has anti-inflammatory properties and tumor suppressor effects in ovarian cancer through inhibition of the metabolic plasticity and mitochondrial bioenergetics; thereby, SPARC inhibits the cancer cell interactions, proliferation, and invasion of ovarian cancer (John et al., 2019; Naczki et al., 2018). The gene discussed is SPARC; the disease is neoplasm.